Every SEC Form 3/4/5 on record for this filer (CIK 1618442) — 34 issuers, 60 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | Filer | 2024-10-17 → 2026-04-30 | 3 | $3M |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 10% owner | 2024-01-30 → 2025-12-15 | 6 | $7M |
| EYPT | EyePoint, Inc. | Filer | 2023-12-06 → 2025-12-08 | 7 | $52M |
| MLTX | MoonLake Immunotherapeutics | Filer | 2023-10-04 → 2025-10-01 | 3 | −$47M |
| BMEA | Biomea Fusion, Inc. | Filer | 2021-04-15 → 2025-08-01 | 9 | $12M |
| OKUR | OnKure Therapeutics, Inc. | Filer | 2024-10-15 → 2025-05-19 | 3 | −$48,357 |
| IMRX | Immuneering Corp | 10% owner · lapsed | 2021-07-29 → 2024-04-03 | 5 | −$3M |
| AMAM | Ambrx Biopharma, Inc. | 10% owner · lapsed | 2023-03-13 → 2023-10-25 | 6 | — |
| GRNA | GreenLight Biosciences Holdings, PBC | Filer · lapsed | 2023-06-08 → 2023-07-24 | 2 | — |
| ERAS | Erasca, Inc. | Director · lapsed | 2021-07-15 → 2023-06-26 | 6 | — |
| VIGL | Vigil Neuroscience, Inc. | Filer · lapsed | 2022-01-06 → 2022-01-13 | 2 | — |
| VTYX | Ventyx Biosciences, Inc. | Filer · lapsed | 2021-10-20 → 2021-10-27 | 2 | — |
| PYXS | Pyxis Oncology, Inc. | Filer · lapsed | 2021-10-07 → 2021-10-15 | 2 | — |
| TYRA | Tyra Biosciences, Inc. | Filer · lapsed | 2021-09-14 → 2021-09-21 | 2 | — |
| ICVX | Icosavax, Inc. | Filer · lapsed | 2021-07-28 → 2021-08-04 | 2 | — |
| AVTE | Aerovate Therapeutics, Inc. | Filer · lapsed | 2021-06-29 → 2021-07-07 | 2 | $7M |
| ELEV | Elevation Oncology, Inc. | 10% owner · lapsed | 2021-06-24 → 2021-07-01 | 2 | — |
| GLUE | Monte Rosa Therapeutics, Inc. | 10% owner · lapsed | 2021-06-23 → 2021-06-30 | 2 | — |
| VERV | Verve Therapeutics, Inc. | Filer · lapsed | 2021-06-16 → 2021-06-23 | 2 | $5M |
| RAIN | Rain Enhancement Technologies Holdco, Inc. | Filer · lapsed | 2021-04-22 → 2021-04-29 | 2 | — |
| DSGN | Design Therapeutics, Inc. | Filer · lapsed | 2021-03-25 → 2021-04-01 | 2 | — |
| RXDX | Prometheus Biosciences, Inc. | 10% owner · lapsed | 2021-03-11 → 2021-03-18 | 3 | $7M |
| BCAB | BioAtla, Inc. | 10% owner · lapsed | 2020-12-15 → 2020-12-22 | 2 | — |
| OLMA | Olema Pharmaceuticals, Inc. | 10% owner · lapsed | 2020-11-18 → 2020-11-23 | 2 | $8M |
| AVIR | Atea Pharmaceuticals, Inc. | 10% owner · lapsed | 2020-11-05 → 2020-11-05 | 1 | — |
| AKUS | Akouos, Inc. | 10% owner · lapsed | 2020-06-25 → 2020-07-02 | 2 | — |
| RNA | Atrium Therapeutics, Inc. | 10% owner · lapsed | 2020-06-11 → 2020-06-18 | 2 | — |
| AXNX | Axonics Modulation Technologies, Inc. | 10% owner · lapsed | 2018-10-30 → 2018-11-02 | 3 | — |
| CNST | CONSTELLATION PHARMACEUTICALS INC | 10% owner · lapsed | 2018-07-18 → 2018-07-20 | 2 | — |
| KZR | Kezar Life Sciences, Inc. | 10% owner · lapsed | 2018-06-20 → 2018-06-27 | 2 | — |
| KNSA | Kiniksa Pharmaceuticals International, plc | 10% owner · lapsed | 2018-05-23 → 2018-05-31 | 2 | — |
| PTI | PROTEOSTASIS THERAPEUTICS, INC. | 10% owner · lapsed | 2016-11-07 → 2017-12-18 | 9 | — |
| APLS | Apellis Pharmaceuticals, Inc. | 10% owner · lapsed | 2017-11-08 → 2017-11-14 | 2 | $15M |
| CLSD | Clearside Biomedical, Inc. | 10% owner · lapsed | 2016-06-13 → 2016-06-13 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| MLTX | 2025-09-30 | Sell | 5,827 | $6.96 | $40,556 | 1,994,173 |
| MLTX | 2025-09-29 | Sell | 2,800,000 | $6.61 | $19M | 2,000,000 |
| MLTX | 2025-09-29 | Sell | 3,390,943 | $7.58 | $26M | 4,800,000 |
| MLTX | 2025-09-29 | Sell | 70,748 | $9.38 | $663,616 | 8,423,403 |
| MLTX | 2025-09-29 | Sell | 232,460 | $8.40 | $2M | 8,190,943 |
| OKUR | 2025-05-12 | Sell | 24,300 | $1.99 | $48,357 | 1,813,439 |
| DRUG | 2024-10-16 | Buy | 39,743 | $23.22 | $922,832 | 864,743 |
| DRUG | 2024-10-16 | Buy | 3,107 | $25.22 | $78,359 | 875,000 |
| DRUG | 2024-10-16 | Buy | 7,150 | $24.03 | $171,815 | 871,893 |
| DRUG | 2024-10-15 | Buy | 4,609 | $12.35 | $56,921 | 825,000 |
18 of 34 issuers are covered and open a security page; the rest are on file here only.
